How do you reconcile this with the company saying they expected TLD in September?
NW management inexperience. They're ability to anticipate timelines has been terrible since they have no experience at commercializing a life science product.
I've had so many conversations with management over the years that I think I'd sense if there was something else going on.
They are being careful at the expense of being timely. Ultimately better for investors.